Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.
By Christopher P. Cannon, William S Weintraub, L. Demopoulos, R. Vicari, Martin J. Frey, N. Lakkis, Franz‐Josef Neumann, D. Robertson, P. Delucca, Peter M DiBattiste and 2 more. New England Journal of Medicine, 2001
1,420 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/8ce9d159ba2f92eed347e3a2cfc6b10a74fbdecd
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2014, methodology): “Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.”